[Molsidomin compared to nitrates. Use in patients with manifest coronary disease].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D002118:Calcium / Q000037:antagonists & inhibitors; D003327:Coronary Disease / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D009566:Nitrates / Q000627:therapeutic use*; D005996:Nitroglycerin / Q000627:therapeutic use; D010069:Oxadiazoles / Q000627:therapeutic use*; D013558:Sydnones / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D009025:Morpholines; D009566:Nitrates; D010069:Oxadiazoles; D013558:Sydnones; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate; D002118:Calcium
Molsidomin im Vergleich zu Nitraten Anwendung bei Patienten mit manifester Koronarinsuffizienz.